NICOLE SHIRK: Open Payments
NPI 1134416399 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 13 payments from 9 companies in 2025. Trend: 2023 $80 · 2024 $576 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Organon LLC | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $19 |
| QOL Medical, LLC | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
Products named: XIFAXAN, ENTYVIO, HADLIMA, RINVOQ, TREMFYA, CREON, Sucraid, EOHILIA.
Industry payments across IN — which companies pay providers there.
